| Spatially fractionated radiation therapy: History, present and the future W Yan, MK Khan, X Wu, CB Simone II, J Fan, E Gressen, X Zhang, ... Clinical and translational radiation oncology 20, 30-38, 2020 | 120 | 2020 |
| SUNSET: Stereotactic radiation for ultracentral non–small-cell lung cancer—A safety and efficacy trial M Giuliani, AS Mathew, H Bahig, SV Bratman, E Filion, D Glick, AV Louie, ... Clinical lung cancer 19 (4), e529-e532, 2018 | 103 | 2018 |
| Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease H Bahig, E Filion, T Vu, J Chalaoui, L Lambert, D Roberge, M Gagnon, ... Practical radiation oncology 6 (5), 367-374, 2016 | 97 | 2016 |
| Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience H Bahig, MP Campeau, T Vu, R Doucet, DB Nadeau, B Fortin, D Roberge, ... International Journal of Radiation Oncology* Biology* Physics 87 (3), 583-589, 2013 | 86 | 2013 |
| Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial AC Nichols, P Lang, E Prisman, E Berthelet, E Tran, S Hamilton, J Wu, ... BMC cancer 20, 1-13, 2020 | 67 | 2020 |
| Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real … A Desilets, F Blanc-Durand, S Lau, T Hakozaki, R Kitadai, J Malo, ... European Journal of Cancer 142, 83-91, 2021 | 61 | 2021 |
| Neutrophil count is associated with survival in localized prostate cancer H Bahig, D Taussky, G Delouya, A Nadiri, A Gagnon-Jacques, ... BMC cancer 15, 1-8, 2015 | 57 | 2015 |
| The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review M Tonneau, A Elkrief, D Pasquier, TP Del Socorro, M Chamaillard, ... Radiotherapy and Oncology 156, 1-9, 2021 | 53 | 2021 |
| Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy (MR-ADAPTOR): an R-IDEAL … H Bahig, Y Yuan, ASR Mohamed, KK Brock, SP Ng, J Wang, Y Ding, ... Clinical and translational radiation oncology 13, 19-23, 2018 | 52 | 2018 |
| Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma H Bahig, F Aubin, J Stagg, O Gologan, O Ballivy, E Bissada, ... BMC cancer 19, 1-15, 2019 | 51 | 2019 |
| Hypofractionated radiation therapy for breast ductal carcinoma in situ L Hathout, T Hijal, V Théberge, B Fortin, H Vulpe, JC Hogue, C Lambert, ... International Journal of Radiation Oncology* Biology* Physics 87 (5), 1058-1063, 2013 | 48 | 2013 |
| Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy SP Ng, C Pollard III, M Kamal, Z Ayoub, AS Garden, H Bahig, GB Gunn, ... NPJ Precision Oncology 3 (1), 22, 2019 | 42 | 2019 |
| Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma H Bahig, A Lapointe, S Bedwani, J de Guise, L Lambert, E Filion, ... European journal of radiology 110, 1-6, 2019 | 41 | 2019 |
| Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy SP Ng, C Pollard III, J Berends, Z Ayoub, M Kamal, AS Garden, H Bahig, ... Cancer 125 (11), 1823-1829, 2019 | 38 | 2019 |
| Predictive factors of survival and treatment tolerance in older patients treated with chemotherapy and radiotherapy for locally advanced head and neck cancer H Bahig, B Fortin, M Alizadeh, L Lambert, E Filion, L Guertin, T Ayad, ... Oral oncology 51 (5), 521-528, 2015 | 37 | 2015 |
| Excellent cancer outcomes following patient-adapted robotic lung SBRT but a case for caution in idiopathic pulmonary fibrosis H Bahig, E Filion, T Vu, D Roberge, L Lambert, M Bouchard, C Lavoie, ... Technology in cancer research & treatment 14 (6), 667-676, 2015 | 35 | 2015 |
| Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: development and validation … J Kang, MS Ning, H Feng, H Li, H Bahig, ED Brooks, JW Welsh, R Ye, ... International Journal of Radiation Oncology* Biology* Physics 106 (1), 90-99, 2020 | 33 | 2020 |
| Assessing lung function using contrast‐enhanced dual‐energy computed tomography for potential applications in radiation therapy A Lapointe, H Bahig, D Blais, H Bouchard, É Filion, JF Carrier, S Bedwani Medical physics 44 (10), 5260-5269, 2017 | 33 | 2017 |
| Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared … ASR Mohamed, H Bahig, M Aristophanous, P Blanchard, M Kamal, ... Clinical and translational radiation oncology 11, 11-18, 2018 | 31 | 2018 |
| A study of pseudoprogression after spine stereotactic body radiation therapy H Bahig, D Simard, L Létourneau, P Wong, D Roberge, E Filion, D Donath, ... International Journal of Radiation Oncology* Biology* Physics 96 (4), 848-856, 2016 | 30 | 2016 |
